174 related articles for article (PubMed ID: 20668838)
1. Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics.
Youns M; Fu YJ; Zu YG; Kramer A; Konkimalla VB; Radlwimmer B; Sültmann H; Efferth T
Naunyn Schmiedebergs Arch Pharmacol; 2010 Sep; 382(3):221-34. PubMed ID: 20668838
[TBL] [Abstract][Full Text] [Related]
2. High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance.
Catts VS; Farnsworth ML; Haber M; Norris MD; Lutze-Mann LH; Lock RB
Leukemia; 2001 Jun; 15(6):929-35. PubMed ID: 11417479
[TBL] [Abstract][Full Text] [Related]
3. HSH2D contributes to methotrexate resistance in human T‑cell acute lymphoblastic leukaemia.
Wang J; Xiong Y
Oncol Rep; 2020 Nov; 44(5):2121-2129. PubMed ID: 33000278
[TBL] [Abstract][Full Text] [Related]
4. Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines.
Efferth T; Verdorfer I; Miyachi H; Sauerbrey A; Drexler HG; Chitambar CR; Haber M; Gebhart E
Blood Cells Mol Dis; 2002; 29(1):1-13. PubMed ID: 12482398
[TBL] [Abstract][Full Text] [Related]
5. Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay.
Rots MG; Pieters R; Kaspers GJ; van Zantwijk CH; Noordhuis P; Mauritz R; Veerman AJ; Jansen G; Peters GJ
Blood; 1999 Feb; 93(3):1067-74. PubMed ID: 9920857
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
Toffoli G; Corona G; Gigante M; Boiocchi M
Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
[TBL] [Abstract][Full Text] [Related]
7. Correlation between decreased apoptosis and multidrug resistance (MDR) in murine leukemic T cell lines.
Lopes EC; García MG; Vellón L; Alvarez E; Hajos SE
Leuk Lymphoma; 2001 Aug; 42(4):775-87. PubMed ID: 11697508
[TBL] [Abstract][Full Text] [Related]
8. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
[TBL] [Abstract][Full Text] [Related]
9. Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques.
Hattinger CM; Reverter-Branchat G; Remondini D; Castellani GC; Benini S; Pasello M; Manara MC; Scotlandi K; Picci P; Serra M
Eur J Cell Biol; 2003 Sep; 82(9):483-93. PubMed ID: 14582536
[TBL] [Abstract][Full Text] [Related]
10. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
[TBL] [Abstract][Full Text] [Related]
11. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines.
Hattinger CM; Stoico G; Michelacci F; Pasello M; Scionti I; Remondini D; Castellani GC; Fanelli M; Scotlandi K; Picci P; Serra M
Genes Chromosomes Cancer; 2009 Apr; 48(4):289-309. PubMed ID: 19105235
[TBL] [Abstract][Full Text] [Related]
13. DOX-MTX-NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes.
Abbasi MM; Khiavi MM; Monfaredan A; Hamishehkar H; Seidi K; Jahanban-Esfahlan R
Asian Pac J Cancer Prev; 2014; 15(19):8377-82. PubMed ID: 25339032
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.
Mencía N; Selga E; Rico I; de Almagro MC; Villalobos X; Ramirez S; Adan J; Hernández JL; Noé V; Ciudad CJ
BMC Cancer; 2010 Jun; 10():250. PubMed ID: 20515499
[TBL] [Abstract][Full Text] [Related]
15. Evolution of drug resistance in CCRF-CEM human leukemia cells selected by intermittent methotrexate exposure.
McGuire JJ; Haile WH; Russell CA; Galvin JM; Shane B
Oncol Res; 1995; 7(10-11):535-43. PubMed ID: 8866666
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic activity of isoliquiritigenin towards CCRF-CEM leukemia cells and its effect on DNA damage.
Zu Y; Liu X; Fu Y; Shi X; Wu N; Yao L; Efferth T
Planta Med; 2009 Aug; 75(10):1134-40. PubMed ID: 19291608
[TBL] [Abstract][Full Text] [Related]
17. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile.
Sorich MJ; Pottier N; Pei D; Yang W; Kager L; Stocco G; Cheng C; Panetta JC; Pui CH; Relling MV; Cheok MH; Evans WE
PLoS Med; 2008 Apr; 5(4):e83. PubMed ID: 18416598
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene.
Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD
Int J Cancer; 1998 Oct; 78(2):176-81. PubMed ID: 9754649
[TBL] [Abstract][Full Text] [Related]
19. [The influence of carbohydrate ligands on the cytotoxicity of liposomes bearing a methotrexate-diglyceride conjugate in human acute leukemia cell cultures].
Kuznetsova NR; Gaenko GP; Khaĭdukov SV; Bovin NV; Vodovozova EL
Bioorg Khim; 2009; 35(4):542-9. PubMed ID: 19928057
[TBL] [Abstract][Full Text] [Related]
20. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate.
Salehi R; Rasouli S; Hamishehkar H
Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
